Learn More
Eurofins Discoverx Dasatinib, 10 mg. (92-1183)
Supplier: Eurofins Discoverx 921183

Dasatinib (Sprycel, BMS-354825) is an oral BCR-ABL, c-KIT, SRC inhibitor (IC50=<1, 79, and 0.8, respectively) and cancer drug developed by Bristol-Myers Squibb. It is most commonly used for treatment of chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Inhibits tyrosine kinases via competing for ATP. Provided as 10 mg of dry powder. These highly purified, pre-validated control ligands have been used to qualify our InCELL Hunter, PathHunter and cAMP Hunter cell lines as well as our Assay Ready Kits. Ligands are conveniently supplied with a recommended reconstitution buffer. For detailed information and product-specific datasheet, visit www.discoverx.com/ligands.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.